Insulin aspart, recombinant Subcutaneous and Peramivir Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Peramivir Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: peramivir
Brand name: Rapivab
Synonyms: Peramivir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Perampanel
- Insulin aspart, recombinant Subcutaneous-Perampanel Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Perampanel Tablets
- Insulin aspart, recombinant Subcutaneous-Peranex HC
- Insulin aspart, recombinant Subcutaneous-Percocet
- Insulin aspart, recombinant Subcutaneous-Percocet 10/325
- Peramivir Intravenous-Insulin degludec
- Peramivir Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Peramivir Intravenous-Insulin Degludec (U-100) Vials
- Peramivir Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Peramivir Intravenous-Insulin degludec and liraglutide
- Peramivir Intravenous-Insulin degludec and liraglutide Subcutaneous